#Molecular Diagnostics
5 articles with this tag
Cyted Health Raises €37.5M Series B for Oesophageal Cancer Diagnostics
Cyted Health secured €37.5 million in Series B financing. EQT Life Sciences, Advent Life Sciences, and British Business Bank led the round. This funding will accelerate the company's US expansion for its oesophageal cancer diagnostics.
Cyted Health Raises €37.5M Series B for Oesophageal Cancer Diagnostics
Cambridge-based Cyted Health secured €37.5 million in its Series B financing. EQT Life Sciences, Advent Life Sciences, and British Business Bank led the round.
German Detechgene Secures €3.2M for Mobile Lab Diagnostics
German biotech Detechgene secured €3.2 million in its second Seed round, led by Neoteq ventures. The company develops 'PCR to Go', a mobile platform for fast, lab-accurate molecular diagnostics. This funding will commercialise its platform, advancing decentralized healthcare diagnostics.
German Detechgene Secures €3.2M for Mobile Lab Diagnostics
Cologne-based biotech startup Detechgene raised €3.2 million in its second Seed round. Neoteq ventures led the investment.
At-Home STI Testing by Visby Medical, Raised $65M
PCR results in under 30 minutes through the world's first instrument-free, single-use PCR tests that fit in the palm of your hand. Currently, Visby Medical offers FDA-cleared tests for sexually transmitted infections (STIs).